-
16 Apr 2024 Job Information Organisation/Company University of Copenhagen Department Novo Nordisk Foundation Center for Basic Metabolic Research Research Field Computer science Researcher Profile
-
. The positions will be embedded in RNA-META, Centre for RNA Therapeutics towards Metabolic Diseases ( https://inano.au.dk/about/research-centers-and-projects/rna-meta/research), founded by Novo Nordisk Foundation
-
starting as soon as possible. Position Description: The position is funded by an Interdisciplinary Synergy Grant from the Novo Nordisk Foundation for the project BioNWire. The project aims to self-assemble a
-
predictions of the response to pharmaceutical treatment. The project is funded by the Novo Nordisk Foundation. Information on the department can be found at: Department of Veterinary and Animal Sciences
-
Skip to main content. Profile Sign Out View More Jobs Professor in Industrial Biotechnology - DTU Biosustain Kgs. Lyngby, Denmark Be the First to Apply Job Description The Novo Nordisk Foundation
-
have it right here. As an internationally reputed elite university, DTU is at the forefront of innovation related to “the sustainable transition.” At the Novo Nordisk Foundation Center
-
Skip to main content. Profile Sign Out View More Jobs Fermentation Specialist - DTU Biosustain Kgs. Lyngby, Denmark Be the First to Apply Job Description The department Novo Nordisk Foundation
-
Postdoc in statistics to develop Bayesian privacy metrics for synthetic health data (2024-224-05725)
scientist, students, and a student helper. The project is a part of the ambitious Novo Nordisk Foundation Data Science Collaborative Programme,“Synthetic health data: ethical development and deployment via
-
part of the Novo Nordisk Foundation Center for Biosustainability. We develop novel yeast cell factories to produce chemicals and natural products in a more sustainable way. We have supportive and
-
), The Novo Nordisk Foundation Center for Stem Cell Medicine (renew) at University of Copenhagen, and Bioneer A/S that aims at developing new in vitro disease models and cell therapies using human induced